MedTrace Logo

Virtual Hope Box - Effectiveness of a Smartphone App for Coping With Suicidal Ideation

NCT01982773 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2018-01-30

Study results available
· View outcomes & findings →

Summary

A hope box or self soothing kit is a therapeutic tool employed by clinicians with patients expressing suicidal ideation, significant distress, or otherwise at risk of suicidal or non-suicidal self harm. A "Virtual Hope Box" (VHB) takes the common hope box practice and uses smartphone features to enhance the experience. The rich multimedia features on a smartphone allow more varied options. Furthermore, these devices are already a common repository for user-generated and user-preferred media, which will allow for a highly personalized VHB that is highly portable and always available to a user in distress. We hypothesize that:

1. Patients in the (VHB) intervention condition will demonstrate pre-post reductions in 1) severity of suicidal ideation 2) ability to cope with stressors and 3) increases in perceived reasons for living
2. Patients in the intervention condition will demonstrate greater pre-post reductions in symptoms of suicidal ideation, ability to cope with stressors, and perceived reasons for living compared to patients in the (ETAU) control condition.
3. Patients and clinicians will find VHB to be beneficial and its use readily integrated into practice.

Conditions

Interventions

BEHAVIORAL

Virtual Hope Box Smartphone App

Smartphone app

BEHAVIORAL

Enhanced Treatment as Usual

Printed materials

Sponsors & Collaborators

  • The Geneva Foundation

    collaborator OTHER

  • Portland VA Medical Center

    collaborator FED

  • National Center for Telehealth and Technology

    lead FED

Principal Investigators

  • Nigel E Bush, PhD · National Center for Telehealth and Technology

  • Steven K Dobscha, MD · Portland VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01982773 on ClinicalTrials.gov